dr. (Pieter) P.H.M. van Baal

All publications (77)

• Article (64)

  • Scholarly Publication (58)

    • W.B.F. Brouwer, P.H.M. van Baal, N.J.A. van Exel & M.M. Versteegh (2018). When is it too expensive? Cost-effectiveness thresholds and health care decision-making. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-1000-4
    • P.H.M. van Baal, A. Morton & J.L. Severens (2018). Health care input constraints and cost effectiveness analysis decision rules. Social Science & Medicine, 200 (March), 59-64. doi: 10.1016/j.socscimed.2018.01.026.
    • P.H.M. van Baal, A. Morton, D. Meltzer & W.B.F. Brouwer (2018). Future unrelated medical costs need to be considered in cost effectiveness analysis. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-018-0976-0
    • P.H.M. van Baal, M.S. Perry-Duxbury, P.L.H. Bakx, M.M. Versteegh, E.K.A. van Doorslaer & W.B.F. Brouwer (2018). A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending. Health Economics, 2018, 1-14. doi: 10.1002/hec.3831
    • P.H.M. van Baal & M. Gheorghe (2017). We leven langer, maar ook in goede gezondheid? Ongelijkheid in voor kwaliteit van leven gecorrigeerde levensverwachting. Nederlands Tijdschrift voor Geneeskunde, 161 (8):D806.
    • F. Alleweldt, S. Kara, A. Osinski, P.H.M. van Baal, K.M. Kellerborg, F.M. Aarestrup & M.P.G. Koopmans (2017). Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data. Revue Scientifique et Technique de l'Office International des Epizooties, 36 (1), 311-322. doi: 10.20506/rst.36.1.2631.
    • R.T. Hoogenveen, H.C. Boshuizen, P. Engelfriet & P.H.M. van Baal (2017). You Only Die Once: Accounting for Multi-Attributable Mortality Risks in Multi-Disease Models for Health-Economic Analyses. Medical Decision Making, 37 (4), 403-414. doi: 10.1177/0272989X16658661
    • M. Gheorghe, S. Picavet, M. Verschuren, W.B.F. Brouwer & P.H.M. van Baal (2017). Health losses at the end of life: a Bayesian mixed beta regression approach. Journal of the Royal Statistical Society. Series A. Statistics in Society, 180 (3), 723-749. doi: 10.1111/rssa.12230[go to publisher's site]
    • P.H.M. van Baal, A. Morton, D.O. Meltzer & W.B.F. Brouwer (2017). Should cost effectiveness analyses for NICE always consider future unrelated medical costs? BMJ-British medical journal, Nov 10, 359-359. doi: 10.1136/bmj.j5096[go to publisher's site]
    • P.H.M. van Baal, M. Hoogendoorn & A. Fischer (2016). Preventing dementia by promoting physical activity and the long-term impact on health and social care expenditures. Preventive Medicine, 85 (4), 78-83. doi: 10.1016/j.ypmed.2016.01.013[go to publisher's site]
    • P.H.M. van Baal, F. Peters, J.P. Mackenbach & W.J. Nusselder (2016). Forecasting differences in life expectancy by education. Population Studies. A Journal of Demography, 70 (2), 201-216. doi: 10.1080/00324728.2016.1159718[go to publisher's site]
    • A. Morton, A.L. Adler, D. Bell, A. Briggs, W.B.F. Brouwer, K. Claxton, N. Craig, A. Fischer, P. McGregor & P.H.M. van Baal (2016). Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal. Health Economics, 25 (8), 933-938. doi: 10.1002/hec.3366[go to publisher's site]
    • M. Gheorghe, P. Wubulihasimu, F. Peters, W.J. Nusselder & P.H.M. van Baal (2016). Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level. European Journal of Public Health, 26 (5), 794-799. doi: 10.1093/eurpub/ckw043[go to publisher's site]
    • P. Wubulihasimu, W.B.F. Brouwer & P.H.M. van Baal (2016). The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries. Health Economics, 25 (8), 1005-1019. doi: http://dx.doi.org/10.1002/hec.3205[go to publisher's site]
    • P.H.M. van Baal, D. Meltzer & W.B.F. Brouwer (2016). Future costs, fixed healthcare budgets and the decision rules of cost-effectiveness analysis. Health Economics, 25 (2), 237-248. doi: http://dx.doi.org/10.1002/hec.3138[go to publisher's site]
    • M. Gheorghe, W.B.F. Brouwer & P.H.M. van Baal (2015). Quality of life and time to death: have the health gains of preventive interventions been underestimated? Medical Decision Making, 35 (3), 316-327. doi: 10.1177/0272989X14555771
    • P.H.M. van Baal (2015). Preventie minder noodzakelijk dankzij betere zorg? Naar een doelmatige inzet van preventie en curatie. Nederlands Tijdschrift voor Geneeskunde, 159 (19).[go to publisher's site]
    • P. Wubulihasimu, W.B.F. Brouwer & P.H.M. van Baal (2015). Does living longer in good health facilitate longer working lives? The relationship between disability and working lives. European Journal of Public Health, 25 (5), 791-795. doi: 10.1093/eurpub/ckv062.
    • M. Gheorghe, W.B.F. Brouwer & P.H.M. van Baal (2015). Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life. European Journal of Health Economics (HEPAC), 16 (8), 801-811. doi: 10.1007/s10198-014-0630-4
    • P. Wubulihasimu, M. Gheorghe, L. Slobbe, J. Polder & P.H.M. van Baal (2014). Trends in Dutch hospital spending by age and disease1994–2010. Health Policy. doi: 10.1016/j.healthpol.2014.11.009
    • I. Grootjans-van Kampen, P. Engelfriet & P.H.M. van Baal (2014). Disease Prevention: Saving Lives or Reducing Health Care Costs? PLoS One (print), 9 (8):e104469. doi: http://dx.doi.org/10.1371/journal.pone.0104469[go to publisher's site]
    • I.M. Majer, R. stevens, W.J. Nusselder, J.P. Mackenbach & P.H.M. van Baal (2013). Modeling and Forecasting Health Expectancy: Theoretical Framework and Application. Demography, 50, 673-697. doi: http://dx.doi.org/10.1007/s13524-012-0156-2[go to publisher's site]
    • L. Mohseninejad, P.H.M. van Baal, M. van den Berg, E. Buskens & T.L. Feenstra (2013). Value of information analysis from a societal perspective: a case study in prevention of major depression. Value in Health, 16 (4), 490-497. doi: http://dx.doi.org/10.1016/j.jval.2012.12.007[go to publisher's site]
    • I.M. Majer, J.P. Mackenbach & P.H.M. van Baal (2013). Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach. Statistics in Medicine, 32, 1561-1571. doi: 10.1002/sim.5558
    • P.H.M. van Baal, D. Meltzer & W.B.F. Brouwer (2013). Pharmacoeconomics Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al. Pharmacoeconomics (Print), 31, 369-373. doi: http://dx.doi.org/10.1007/s40273-013-0042-9[go to publisher's site]
    • T.A. Kanters, W.B.F. Brouwer, R.C.J.A. van Vliet, P.H.M. van Baal & J. Polder (2013). A new prevention paradox: The trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers. Social Science & Medicine, 76, 150-158. doi: http://dx.doi.org/10.1016/j.socscimed.2012.10.019[go to publisher's site]
    • P.H.M. van Baal (2012). Important cost categories not included: transcatheter aortic valve implantation probably less cost-effective. Heart, 98, 1182-1182. doi: http://dx.doi.org/10.1136/heartjnl-2012-302272
    • J. van de Kassteele, R.T. Hoogenveen, P.M. Engelfriet, P.H.M. van Baal & H.C. Boshuizen (2012). Estimating net transition probabilities from cross-sectional data with application to risk factors in chronic disease modeling. Statistics in Medicine, 31, 533-543. doi: http://dx.doi.org/10.1002/sim.4423
    • E. Over, W. Wendel-Vos, M. Berg, H. Hamberg-van Reenen, L. Tariq, R.T. Hoogenveen & P.H.M. van Baal (2012). Cost-effectiveness of counseling and pedometer use to increase physical activity in the Netherlands: a modeling study. Cost Effectiveness and Resource Allocation, 10 (1), 1-7. doi: http://dx.doi.org/10.1186/1478-7547-10-13
    • H.C. Boshuizen, S.K. Lhachimi, P.H.M. van Baal, R.T. Hoogenveen, H.A. Smit, J.P. Mackenbach & W.J. Nusselder (2012). The DYNAMO-HIA Model: An Efficient Implementation of a Risk Factor/Chronic Disease Markov Model for Use in Health Impact Assessment (HIA). Demography, 49 (4), 1259-1283. doi: 10.1007/s13524-012-0122-z
    • S.K. Lhachimi, W.J. Nusselder, H.A. Smit, P.H.M. van Baal, P. Baili, K. Bennett, E. Fernandez, M.C. Kulik, T. Lobstein, J. Pomerleau, J.P. Mackenbach & H.C. Boshuizen (2012). DYNAMO-HIA-A Dynamic Modeling Tool for Generic Health Impact Assessments. PLoS One (print), 7 (5), 1-11. doi: http://dx.doi.org/10.1371/journal.pone.0033317
    • C.A.M. de Meijer, I.M. Majer, M.A. Koopmanschap & P.H.M. van Baal (2012). Forecasting Lifetime and Aggregate Long-term Care Spending Accounting for Changing Disability Patterns. Medical Care, 50 (8), 722-729. doi: 10.1097/MLR.0b013e31824ebddc
    • C.A.M. De Meijer, M. Majer, M.A. Koopmanschap & P.H.M. van Baal (2012). Forecasting Lifetime and Aggregate Long-term Care Spending - Accounting for Changing Disability Patterns. Medical Care, 50 (8), 722-729. doi: http://dx.doi.org/10.1097/MLR.0b013e31824ebddc
    • P.H.M. van Baal & A. Wong (2012). Time to death and the forecasting of macro-level health care expenditures: Some further considerations. Journal of Health Economics, 31 (2012), 876-887. doi: http://dx.doi.org/10.1016/j.jhealeco.2012.08.003
    • I.M. Majer, J.P. Mackenbach & P.H.M. van Baal (2012). Time trends and forecasts of body mass index from repeated cross-sectional data: a different approach. Statistics in Medicine. doi: http://dx.doi.org/10.1002/sim.5558[go to publisher's site]
    • P.H.M. van Baal, P.M. Engelfriet, H.C. Boshuizen, J. van de Kassteele, F.G. Schellevis & R.T. Hoogenveen (2011). Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantigying age patterns in the Dutch population using health survey data. Population Health Metrics, 9 (51), 1-9. doi: http://dx.doi.org/10.1186/1478-7954-9-51
    • M. van den Berg, F. Smit, T. Vos & P.H.M. van Baal (2011). Cost-Effectiveness of Opportunistic Screening and Minimal Contact Psycotherapy to Prevent Depression in Primary Care Patients. PLoS One (print), 6 (87), 1-7. doi: http://dx.doi.org/10.1371/journal.pone.0022884
    • R. Heijink, P.H.M. van Baal, M. Oppe, X.H.E. Koolman & G.P. Westert (2011). Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets. Population Health Metrics, 9 (17), 1-11. doi: http://dx.doi.org/10.1186/1478-7954-9-17
    • I.M. Majer, W.J. Nusselder, J.P. Mackenbach, B. Klijs & P.H.M. van Baal (2011). Mortality Risk Associated With Disability: A Population-Based Record Linkage Study. American Journal of Public Health, 101 (12), 9-15. doi: http://dx.doi.org/10.2105/AJPH.2011.300361
    • P.H.M. van Baal, P. Engelfriet, R.T. Hoogenveen, M.J.J.C. Poos, C. van den Dungen & H.C. Boshuizen (2011). Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty. BMC Public Health, 11 (163), 1-11. doi: http://dx.doi.org/10.1186/1471-2458-11-163
    • P. Engelfriet, R.T. Hoogenveen, H.C. Boshuizen & P.H.M. van Baal (2011). To die with or from heart failure: a difference that counts. Is heart failure underrepresented in national mortality statistics. European Journal of Heart Failure, 13, 377-383.
    • P.H.M. van Baal, T.L. Feenstra, J.J. Polder, R.T. Hoogenveen & W.B.F. Brouwer (2011). Economic Evaluation and the postponement of health care costs. Health Economics, 20, 432-445. doi: http://dx.doi.org/10.1002/hec.1599
    • P.H.M. van Baal, A. Wong, L.C.J. Slobbe, J.J. Polder, W.B.F. Brouwer & G.A. de Wit (2011). Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations. Pharmacoeconomics (Print), 29 (3), 175-187. doi: http://dx.doi.org/10.2165/11586130-000000000-00000[go to publisher's site]
    • A. Wong, P.H.M. van Baal, H.C. Boshuizen & J.J. Polder (2011). Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings. Health Economics, 20 (4), 379-400. doi: http://dx.doi.org/10.1002/hec.1597[go to publisher's site]
    • P.H.M. van Baal & W.B.F. Brouwer (2011). PAID 1.0 in Practice A Brief Clarification Regarding its Possibilities and Limitations. Pharmacoeconomics (Print), 29 (6), 545-547. doi: http://dx.doi.org/10.2165/11585600-000000000-00000
    • T.L. Feenstra, P.H.M. van Baal, M.O. Jacobs-van der Bruggen, R.T. Hoogenveen, G.J. Kommer & C.A. Baan (2011). Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention. Cost Effectiveness and Resource Allocation, 9 (14), 1-11. doi: http://dx.doi.org/10.1186/1478-7547-9-14
    • D.R. Rappange, W.B.F. Brouwer, F.F.H. Rutten & P.H.M. van Baal (2010). Lifestyle intervention: from cost savings to value for money. Journal of Public Health, 32 (3), 440-447. doi: http://dx.doi.org/10.1093/pubmed/fdp079
    • P.H.M. van Baal & T.L. Feenstra (2010). Long-term effects of alcohol policies: an economic perspective. Addiction, 105, 395-396. doi: http://dx.doi.org/10.1111/j.1360-0443.2009.02847.x
    • P.H.M. van Baal, R.T. Hoogenveen, H.C. Boshuizen & P. Engelfriet (2010). Indirect Estimation of Chronic Disease Excess Mortality. Epidemiology, 21 (3), 1-2. doi: http://dx.doi.org/10.1097/EDE.0b013e3181d7773f
    • M.A.M. Jacobs-van der Bruggen, A. Spijkerman, P.H.M. van Baal, C.A. Baan, E.J.M. Feskens, H.S. Picavet, D.L. van der A & W.M. Verschuren (2010). Weight Change and Incident Diabetes: Addressing an Unresolved Issue. American Journal of Epidemiology, 172 (3), 263-270. doi: http://dx.doi.org/10.1093/aje/kwq134
    • D.R. Rappange, P.H.M. van Baal, N.J.A. van Exel, T.L. Feenstra, F.F.H. Rutten & W.B.F. Brouwer (2009). I costi sanitari indiretti (non correlati) durante gli anni di vita guadagnati: : Devono essere inclusi nelle valutazioni economiche degli interventi sanitari? Pharmacoeconomics Italian Research Articles, 11 (1), 55-70.
    • D.R. Rappange, W.B.F. Brouwer, R.T. Hoogenveen & P.H.M. van Baal (2009). Healthcare Costs and Obesity Prevention Drug Costs and Other Sector-Specific Consequences. Pharmacoeconomics (Print), 27 (12), 1031-1044. doi: http://dx.doi.org/10.2165/11319900-000000000-00000
    • D.R. Rappange, P.H.M. van Baal, F.F.H. Rutten, N.J.A. van Exel, T.L. Feenstra & W.B.F. Brouwer (2008). Unrelated medical costs in life-years gained should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics (Print), 26 (10), 815-860. doi: http://dx.doi.org/10.2165/00019053-200826100-00003
    • T.L. Feenstra, P.H.M. van Baal, A. Gandjour & W.B.F. Brouwer (2008). Future medical costs in economic evaluations. A comment on Lee. Journal of Health Economics, 27 (6), 1645-1649. doi: http://dx.doi.org/10.1016/j.jhealeco.2008.07.007
    • P.H.M. van Baal, J.J. Polder, G.A. de Wit, R.T. Hoogeveen, T.L. Feenstra, H.C. Boshuizen, P. Engelfriet & W.B.F. Brouwer (2008). Lifetime medical costs of obesity: pevention no cure for increasing health expenditure. PLoS Medicine (print), 5 (2), 242-249. doi: http://dx.doi.org/10.1371/journal.pmed.0050029
    • P.H.M. van Baal, W.B.F. Brouwer, R.T. Hoogeveen & T.L. Feenstra (2007). Increasing tobacco taxes: A cheap tool to increase public health. Health Policy, 82, 142-152. doi: http://dx.doi.org/10.1016/j.healthpol.2006.09.004
    • W.B.F. Brouwer, N.J.A. van Exel, P.H.M. van Baal & J. Polder (2007). Economics and public health: Engaged to be happily married! European Journal of Public Health, 17 (2), 122-123. doi: http://dx.doi.org/10.1093/eurpub/ckl074
    • P.H.M. van Baal, T.L. Feenstra, R.T. Hoogenveen, G.A. de Wit & W.B.F. Brouwer (2007). Unrealated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio. Health Economics, 16, 421-433. doi: http://dx.doi.org/10.1002/hec.1181

  • Professional Publication (6)

    • P.H.M. van Baal (2010). Economische evaluaties en de zorgkosten van levensverlenging. VGE Bulletin, 3, 26-28.
    • W.B.F. Brouwer, N.J.A. van Exel & P.H.M. van Baal (2008). Kosten in de gewonnen levensjaren niet langer negeren! TSG, 86 (1), 1-1.
    • P.H.M. van Baal, W.B.F. Brouwer, G.A. de Wit, R.T. Hoogeveen & J.J. Polder (2008). De invloed van roken en overgewicht op zorguitgaven. TSG, 86 (3), 150-155.
    • W.B.F. Brouwer, N.J.A. van Exel & P.H.M. van Baal (2007). De kosten in gewonnen levensjaren - tijd voor een nieuwe richtlijn! VGE Bulletin, 24 (1), 11-14.
    • W.B.F. Brouwer, N.J.A. van Exel, J. Polder & P.H.M. van Baal (2006). Gezond leven niet per se goedkoper. Medisch Contact, 61 (21), 878-881.
    • W.B.F. Brouwer, P.H.M. van Baal & N.J.A. van Exel (2006). De dubbele prijs van succes: The pain is in the gain. TSG, 84, 7-10.

• Part of book - Chapter (4)

  • Scholarly Publication (1)

    • P.H.M. van Baal, H. Elffers & D.J. Hessing (2000). These: A System for Simulations of Rule-Breaking Behavior. In E. Hoelz (Ed.), Conference Proceedings Fairness and Cooperation (pp. 467-470). Vienna: IAREP/SABE

  • Professional Publication (3)

    • N.J.A. van Exel, P.H.M. van Baal & W.B.F. Brouwer (2011). Prikkels voor gezond gedrag: een gezonde zaak? In HW van Lienden & JMD Boot (Eds.), Economie van de volksgezondheid: zorg voor gezondheid=zorg voor welvaart. Assen: van Gorcum
    • J. Polder, P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2007). Preventie: niet altijd goedkoop, wel vaak een goede koop. Een economisch verhaal over preventie en de waarde van gezondheid. In Jaarboek Publieke Gezondheid (pp. 128-3). Abcoude: Stichting Public Health Forum
    • J.J. Polder, P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2007). Een economisch verhaal over preventie en de waarde van gezondheid. In Jaarboek Publieke Gezondheid 2007 (pp. 128-3). Abcoude: Stichting Public Health Forum

• Report (5)

  • Scholarly Publication (3)

    • P.H.M. van Baal, N.J.A. van Exel & W.B.F. Brouwer (2015). Kosten van langer leven en de evaluatie van medische technologie. (Extern rapport, Opinion Paper 64). Tilburg: Netspar
    • P.H.M. van Baal, P. Obulqasim, W.B.F. Brouwer, W. Nusselder & J. Mackenbach (2013). The influence of health care spending on life expectancy. (Extern rapport). Tilburg: Netspar Panel Papers
    • H. Elffers, F.H. Barwegen, D.J. Hessing & P.H.M. van Baal (2000). Naleving van belastingregels, een literatuurinventarisatie 1992-1998. (Intern rapport, no 1). :

  • Professional Publication (2)

    • H. Elffers, F.H. Barwegen, D.J. Hessing & P.H.M. van Baal (1999). Naleving van Belastingregels. (Extern rapport, no 2). Rotterdam: Erasmus Centre for Sociolegal Tax Research
    • P.H.M. van Baal, P.J. de Koning & D.J. Hessing (1999). Naar een model van kosten-effectiviteit van Justitiële Inrichtingen. (Extern rapport, no 1). Rotterdam: Onderzoekschool Maatschappelijke Veiligheid

• Book / Monograph / Book editorial (1)

  • W.B.F. Brouwer, F.F.H. Rutten, J.L. Severens, P.H.M. van Baal, T.E.D. van der Grinten, A.H.E. Koolman & N.J.A. van Exel (2011). Economie van de volksgezondheid. Assen: Koninklijke van Gorcum BV

• Doctoral thesis (1)

  • P.H.M. van Baal (2004, april 1). Computer Simulations of Criminal Deterrence. Erasmus Universiteit Rotterdam (171 pag.) (Den Haag: Boom Juridische Uitgevers) Prom./coprom.: prof.mr. R.V. De Mulder.

• Supervised Theses (2)

  • M. Gheorghe (2016, september 15). Quantitative Approaches in Monitoring Population Quality Of Life. EUR Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. P.H.M. van Baal.
  • I.M. Majer (2012, juni 22). Modelling and forecasting health expectancy. EUR (210 pag.) Prom./coprom.: Prof. Dr. J.P. Mackenbach & dr. P.H.M. van Baal.

Ancillary activities (1)

Editorial positions (1)

Present position

Other positions (1)